China’s CanSino Biologics has 16 vaccine candidates in the pipeline, including Covid-19 and meningitis. Photo: Reuters
Pfizer endorses CanSino’s meningitis vaccine, giving Chinese biotech company a shot in the arm
- US global pharmaceutical giant Pfizer will promote Hong Kong-listed CanSino Biologics’ Menhycia meningitis vaccine candidate in the mainland
- China National Medical Products Administration put the vaccine on the fast track list in December, but has yet to approve it
Topic |
Coronavirus pandemic
China’s CanSino Biologics has 16 vaccine candidates in the pipeline, including Covid-19 and meningitis. Photo: Reuters